Millennium Management LLC has recently announced that it has increased stake in Twist Bioscience Corp (NASDAQ:TWST) by 52.74%. After grabbing 3.81 million shares, the institutional investor is now in possession of 1.32 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.65% having worth around $60.12 million.
Twist Bioscience Corp (TWST) concluded trading on 12/14/23 at a closing price of $35.12, with 4.06 million shares of worth about $142.42 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 88.72% during that period and on Thursday the price saw a gain of about 12.53%. Currently the company’s common shares owned by public are about 57.56M shares, out of which, 55.21M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 135 times over the past 12 months. They bought 979,506 shares in 37 of the transactions. In 98 selling transactions, insiders dumped 76,544 shares.
ARK Innovation ETF, SPDR S&P Biotech ETF, and ARK Genomic Revolution ETF are the top 3 mutual funds which are holding stakes in Twist Bioscience Corp ARK Innovation ETF is currently holding 3.65 million shares of worth totaling $57.47 million. The company recently came selling 10570.0 shares which brought its stake up to 6.35% of the company’s outstanding shares. SPDR S&P Biotech ETF bought 17556.0 shares, after which its hold over company’s outstanding shares expand to 5.12%, leaving 2.94 million shares with the mutual fund that have a worth of about $46.29 million. ARK Genomic Revolution ETF, after selling 2.84 million shares, have now control over 4.94% of the stake in the company. It holds 13746.0 shares of worth $44.7 million.
However, the stock later moved at a day high price of 35.63, or with a gain of 12.53%. Stock saw a price change of 32.98% in past 5 days and over the past one month there was a price change of 78.55%. Year-to-date (YTD), TWST shares are showing a performance of 47.50% which increased to 32.73% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $11.46 but also hit the highest price of $31.51 during that period. The average intraday trading volume for Twist Bioscience Corp shares is 1.07 million. The stock is currently trading 41.00% above its 20-day simple moving average (SMA20), while that difference is up 72.71% for SMA50 and it goes to 87.12% higher than SMA200.
Millennium Management LLC acquired 3.81 million shares of Twist Bioscience Corp having value of about $60.12 million. Data submitted at the U.S SEC by Millennium Management LLC revealed that the firm now holds 1.32 million shares in the company valued at close to $46259923.52, or have control over 52.74% stake in the company. Twist Bioscience Corp (NASDAQ: TWST) currently have 57.56M outstanding shares and institutions hold larger chunk of about 109.64% of that. Holding of mutual funds in the company is about 39.26% while other institutional holders and individual stake holders have control over 71.06% and 14.72% of the stake respectively.
The stock has a current market capitalization of $2.03B and its 3Y-monthly beta is at 1.49. It has posted earnings per share of -$3.60 in the same period. It has Quick Ratio of 5.35 while making debt-to-equity ratio of 0.15. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TWST, volatility over the week remained 9.46% while standing at 7.86% over the month.
Analysts are in expectations that Twist Bioscience Corp (TWST) stock would likely to be making an EPS of $Tempest Therapeutics, Inc. in the current quarter, while forecast for next quarter EPS is $4.09 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $Twist Bioscience Corporation which is $Carrols Restaurant Group, Inc. at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $West Pharmaceutical Services, I in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 17.89% while it is estimated to increase by 15.39% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Berenberg on September 27, 2023 offering a Buy rating for the stock and assigned a target price of $27 to it.
